Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 Oct;96(4):482-9.
doi: 10.1038/clpt.2014.137. Epub 2014 Jun 24.

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems

Affiliations
Multicenter Study

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems

L J Rasmussen-Torvik et al. Clin Pharmacol Ther. 2014 Oct.

Abstract

We describe here the design and initial implementation of the eMERGE-PGx project. eMERGE-PGx, a partnership of the Electronic Medical Records and Genomics Network and the Pharmacogenomics Research Network, has three objectives: (i) to deploy PGRNseq, a next-generation sequencing platform assessing sequence variation in 84 proposed pharmacogenes, in nearly 9,000 patients likely to be prescribed drugs of interest in a 1- to 3-year time frame across several clinical sites; (ii) to integrate well-established clinically validated pharmacogenetic genotypes into the electronic health record with associated clinical decision support and to assess process and clinical outcomes of implementation; and (iii) to develop a repository of pharmacogenetic variants of unknown significance linked to a repository of electronic health record-based clinical phenotype data for ongoing pharmacogenomics discovery. We describe site-specific project implementation and anticipated products, including genetic variant and phenotype data repositories, novel variant association studies, clinical decision support modules, clinical and process outcomes, approaches to managing incidental findings, and patient and clinician education methods.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

A.A.V.--Intellectual Property/Royalty Income: Cinncinnati Childrens’ Hospital and Medical Center holds a license agreement on a pharmacogenetics interpretation algorithm. I am an inventor, and I have received royalties from the company to which this has been licensed; E.B--Intellectual Property/Shareholder: I am a co-inventor of web-enabled technology for collecting and utilizing healthcare data, and I hold shares in a company that is licensing this technology from Mount Sinai School of Medicine; E.B.L. I receive royalties from UpToDate from authoring several sections.

Figures

Figure 1
Figure 1
eMERGE PGx Project Design

References

    1. Green ED, Guyer MS National Human Genome Research I. Charting a course for genomic medicine from base pairs to bedside. Nature. 2011;470:204–13. - PubMed
    1. Collins F. Opportunities and challenges for the NIH--an interview with Francis Collins. Interview by Robert Steinbrook. N Engl J Med. 2009;361:1321–3. - PubMed
    1. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363:301–4. - PubMed
    1. McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Putting science over supposition in the arena of personalized genomics. Nat Genet. 2008;40:939–42. - PMC - PubMed
    1. Mardis ER. Next-generation sequencing platforms. Annual review of analytical chemistry. 2013;6:287–303. - PubMed

Publication types

Grants and funding